ClinicalTrials.Veeva

Menu

Turkish Version of the Glaucoma Quality of Life-15 Questionnaire

A

Acibadem University

Status

Completed

Conditions

Quality of Life
Glaucoma

Treatments

Behavioral: Determining quality of life

Study type

Observational

Funder types

Other

Identifiers

NCT03967145
ATADEK 2019-7/2

Details and patient eligibility

About

Glaucoma is a disease with irreversible loss of visual field and optic neuropathy and is the most important cause of irreversible vision loss after cataract in the world. Although clinical evaluations reveal the level of glaucoma quantitatively, it is necessary to evaluate the impact of this pathology on daily functions and quality of life with a holistic perspective and to provide appropriate advice to patients according to the information obtained. Glaucoma Quality of Life -15 Questionnaire (GQoL-15) was developed by Nelson et al. in 2003 to evaluate the quality of life of glaucoma patients. The aim of this study is to translate GQoL-15 into Turkish and evaluate its test-retest reliability for Turkish-speaking population.

Enrollment

127 patients

Sex

All

Ages

20 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of primary open angle glaucoma more than 6 months with visual field tests,
  • Have the sufficient cognitive level to answer the scale questions.

Exclusion criteria

  • To have retinal or optic nerve pathologies that may cause loss of visual field or decrease in visual field except glaucoma,
  • To undergo eye surgery in the last 3 months.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems